CN1200278A - Traditional Chinese medicine prepn. for treating cardiovascular and cerebrovascular disease - Google Patents
Traditional Chinese medicine prepn. for treating cardiovascular and cerebrovascular disease Download PDFInfo
- Publication number
- CN1200278A CN1200278A CN 97105867 CN97105867A CN1200278A CN 1200278 A CN1200278 A CN 1200278A CN 97105867 CN97105867 CN 97105867 CN 97105867 A CN97105867 A CN 97105867A CN 1200278 A CN1200278 A CN 1200278A
- Authority
- CN
- China
- Prior art keywords
- blood
- radix
- cerebrovascular disease
- cardiovascular
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese traditional medicinal recipe for treating cardiocerebral vascular disease is composed of 14 Chinese medicinal herbs including : Ramulus Loranthi, Caulis Spatholobi, Lumbricus, Radix Salviae, safflower, astragalus root, Herba Cynomorii, ligusticum root, Radix Cyathulae, Rhizoma Arisaematis, Bulbus Allii Macrostemi, Semen Strychni etc. which are dried and ground into powder, then processed into different types of medicine. Its effective rate is 100% and curing rate is higher than 90%.
Description
The present invention relates to a kind of Chinese herbal and crude drugs preparations, specifically a kind of Chinese medicine preparation for the treatment of cardiovascular and cerebrovascular disease.
Cerebrovascular disease and cardiovascular disease are commonly encountered diseases and the frequently-occurring diseases in the middle-aged and elderly people.Along with the rhythm of the modern life, the change of dietary structure, the sickness rate of cardiovascular and cerebrovascular vessel obviously improves.According in 1992 incomplete statistics of WHO, whole world evidence of coronary heart diseases is 10.4%.According to ministry of Health of China door statistics, crowd's sickness rate of coronary heart disease is 9.8%, accounts for second of all sickness rate of crowd.In crowd's disease death quantity, the death toll of cardiovascular and cerebrovascular vessel is only second to tumor, accounts for second.According to the existing patient who suffers from cardiovascular and cerebrovascular disease in the population health status investigation of the hygiene department statistics whole nation more than 9,000 ten thousand people are arranged approximately, annually still increase progressively with 4.5% numeral, the number of dying from cardiovascular and cerebrovascular disease every year is up to more than 900 ten thousand.
At present, the medicine of treatment cardiovascular and cerebrovascular disease mainly contains two big classes, and promptly Western medicine and Chinese patent medicine because cardiovascular and cerebrovascular disease is a chronic disease, in doctor trained in Western medicine, mainly is confined to the alleviation of patient symptom, and the symptomatic treatment of pathology is lacked effective means.Thereby majority attends to use Chinese patent medicine, and the Chinese patent medicine that uses at each hospital clinical has five big classes, and a class is based on blood fat reducing; Second class is based on cholesterol reducing; The 3rd class is based on blood vessel dilating; The 4th class is to regulate heart joint rate; Last class is to improve cardiac function.Attempt use Chinese medicine to treat coronary heart disease though have in recent years both at home and abroad, all do not obtain bigger progress.The Chinese patent medicine of the special for treating coronary heart disease of for example having developed has SHANHAI PILL, YANGMINGBAO, heart pill, SUXIAO JIUXIN DAN etc., though said medicine has certain curative effect to cardiovascular and cerebrovascular diseases, but can not reduce blood fat denseness and the chloasma of cleaning internal blood vessel in the blood effectively, can't treat and control the outbreak of cardiovascular and cerebrovascular disease effectively.
The Chinese medicine preparation of the treatment cardiovascular and cerebrovascular disease that the purpose of this invention is to provide a kind of curative effect height, has no side effect.
The effect of the Chinese medicine preparation of treatment cardiovascular and cerebrovascular disease of the present invention is regulate yin-yang, dredge the meridian passage, blood-activating and qi-promoting, eliminating stasis and resolving masses, blood pressure lowering, blood fat reducing, blood sugar lowering, cholesterol reducing, eliminating phlegm and removing dampness, relieving spasm by subduing liver-wind, the refreshment of having one's ideas straightened out promote the blood of human body circulation, improve the immunity of human body, strengthen metabolism, regulate body resistance against diseases, brain-strengthening lengthens one's life.When preventing cardiovascular and cerebrovascular disease, also can prevent the generation of malignant disease, make the whole body twelve channels and collaterals unblocked, coronary heart disease and cerebral thrombosis had significant therapeutical effect, take during general cerebral thrombosis morbidity behind this medicine that effective percentage is 100% in 30 days, cure rate is 92%, patients with coronary heart disease effective percentage in taking this medicine 60 days is 100%, and cure rate is 90%.
The Chinese medicine preparation side of treatment cardiovascular and cerebrovascular disease of the present invention separates as follows:
Herba Taxilli: dredge the meridian passage, the benefit that nourishes blood essence, expansion artery increases blood supply flow coronarius, has the effect of blood fat reducing, blood sugar lowering, cholesterol reducing.
Caulis Spatholobi: have promoting the circulation of blood and enrich blood, relaxing muscles and tendons and activating QI and blood in the collateral, effects such as blood flow increasing.
Pheretima: have the heat clearing away relieving convulsion, collateral dredging is treated numbness, clearing lung, relieving asthma, and inducing diuresis for treating stranguria syndrome, the diastole bronchus brings high blood pressure down, and reduces headache, dizzy, fidgety function of being insomnia that coronary atherosclerosis causes.
Radix Salviae Miltiorrhizae: it act as: blood circulation promoting and blood stasis dispelling, and relieving restlessness is calmed the nerves, reducing swelling and alleviating pain, the expansion peripheral vessels brings high blood pressure down, blood fat reducing, cholesterol reducing, the removing heat from blood detumescence, relieving restlessness clears away heart-fire.
The function of Flos Carthami is: promoting blood circulation to restore menstrual flow, and stasis-dispelling and pain-killing, coronary artery dilator increases the coronary artery blood flow, brings high blood pressure down blood fat reducing, cholesterol reducing, excited intestinal tube, blood vessel and bronchial smooth muscle.
Acting as of the Radix Astragali: tonifying Qi and lifting yang, strengthening superficial resistance to stop perspiration, holder skin ulcer granulation promoting, inducing diuresis to remove edema is strengthened heart contraction, brings high blood pressure down, blood vessel dilating, it is capable to improve blood, and the myocyte of evil idea of a specified duration is rejuvenated, the while stimulating central nervous system, the liver protecting prevents that liver glycogen from reducing.
Acting as of Herba Cynomorii: the kidney invigorating nourishing the liver, tonifying YANG is moisturized, and has treatment kidney yin limb to wither, sufficient knee joint weakness, the wither function of paralysis of insufficiency of kidney-YANG, impotence and seminal emission, limb.
Acting as of Rhizoma Chuanxiong: blood-activating and qi-promoting, wind-expelling pain-stopping, paralysis nervus centralis, antalgic and sedative, excited respiratory center, vasomotor center is directly expanded peripheral vessels, coronary blood flow increasing, with the blood flow of lower limb body, cholesterol reducing, blood fat reducing, blood pressure lowering.
Acting as of Radix Cyathulae: promoting blood circulation to restore menstrual flow, the sharp numbness of Shujin, blood vessel dilating brings high blood pressure down, the liver and the kidney tonifying, strong muscles and bones.
Acting as of Rhizoma Arisaematis: dispel the wind separate through, cure mainly meridians wind-phlegm persistent ailment, accumulation and obstruction of sputum, the stupid fiber crops of brothers, hemiplegia, facial hemiparalysis, disease such as dizzy.
Acting as of Ramulus Uncariae Cum Uncis: the spasmolytic that relieves dizziness, high fever, infantile convulsions, epilepsy, etc., calming liver and clearing heat, the excited breathing, the expansion peripheral vessels brings high blood pressure down, and removes spasm, antalgic and sedative.
The Bulbus Allii Macrostemonis activating YANG and eliminating stagnation cures mainly dyspnea and expectoration, chest pain radiating to the back, the diseases such as the thoracic obstruction, coronary atherosclerosis, angina pectoris of breathing hard.
Acting as of Radix Rehmanniae: the heat clearing away YIN nourishing, cooling blood for hemostasis, the cough-relieving of promoting the production of body fluid strengthens cardiac muscle, blood vessel dilating, expansion renal blood vessels, blood sugar lowering.
Semen Strychni: the meridian dredging pain that relieves the pain, dissipating blood stasis for subsidence of swelling, the treatment paralysis of the limbs, hemiplegia, stimulating central nervous system, excited brain excited nerve such as distinguishes the flavor of, touches, smells, listens, looks.
The Chinese medicine preparation of treatment cardiovascular and cerebrovascular disease of the present invention, its prescription weight percent consists of Herba Taxilli 6-10%, Caulis Spatholobi 6-10%, Pheretima 3-7%, Radix Salviae Miltiorrhizae 8-12%, Flos Carthami 6-10%, Radix Astragali 6-10%, Herba Cynomorii 8-12%, Rhizoma Chuanxiong 8-12%, Radix Cyathulae 8-12%, Rhizoma Arisaematis 3-7%, Ramulus Uncariae Cum Uncis 2-6%, Bulbus Allii Macrostemonis 3-7%, Radix Rehmanniae 2-6%, Semen Strychni 3-7%.
Compound method: make Chinese patent medicines such as powder, pill, tablet or capsule with being ground into fine powder after above-mentioned each Chinese medicine oven dry.
Embodiment:
Prescription one: (counting by weight percentage)
Herba Taxilli 9%, Caulis Spatholobi 9%, Pheretima 5%, Radix Salviae Miltiorrhizae 10%, Flos Carthami 8%, the Radix Astragali 8%, Herba Cynomorii 10%, Rhizoma Chuanxiong 10%, Radix Cyathulae 12%, Rhizoma Arisaematis 3%, Ramulus Uncariae Cum Uncis 2%, Bulbus Allii Macrostemonis 7%, Radix Rehmanniae 4%, Semen Strychni 5%.
Prescription two: (counting by weight percentage)
Herba Taxilli 6%, Caulis Spatholobi 6%, Pheretima 3%, Radix Salviae Miltiorrhizae 12%, Flos Carthami 10%, the Radix Astragali 6%, Herba Cynomorii 12%, Rhizoma Chuanxiong 12%, Radix Cyathulae 12%, Rhizoma Arisaematis 7%, Ramulus Uncariae Cum Uncis 4%, Bulbus Allii Macrostemonis 4%, Radix Rehmanniae 4%, Semen Strychni 4%.
Prescription three: (counting by weight percentage)
Herba Taxilli 9%, Caulis Spatholobi 8%, Pheretima 7%, Radix Salviae Miltiorrhizae 8%, Flos Carthami 11%, the Radix Astragali 6%, Herba Cynomorii 8%, Rhizoma Chuanxiong 7%, Radix Cyathulae 11%, Rhizoma Arisaematis 6%, Ramulus Uncariae Cum Uncis 5%, Bulbus Allii Macrostemonis 3%, Radix Rehmanniae 6%, Semen Strychni 5%.
Optimum formula: (counting by weight percentage)
Herba Taxilli 8%, Caulis Spatholobi 8%, Pheretima 6%, Radix Salviae Miltiorrhizae 10%, Flos Carthami 10%, the Radix Astragali 6%, Herba Cynomorii 8%, Rhizoma Chuanxiong 9%, Radix Cyathulae 10%, Rhizoma Arisaematis 5%, Ramulus Uncariae Cum Uncis 5%, Bulbus Allii Macrostemonis 5%, Radix Rehmanniae 5%, Semen Strychni 5%.
Compound method: the Chinese herbal medicine in above-mentioned each prescription is ground into fine powder after drying respectively makes Chinese patent medicines such as powder, pill, tablet or capsule.
Cure mainly: cardiovascular and cerebrovascular disease, formation phase and convalescent care to cardiovascular and cerebrovascular disease have special effect, and, cerebral thrombosis, hypertension uneven to arteriosclerosis, angina cordis, coronary heart disease, rheumatic heart disease, deficiency myocardial blood supply, heart failure, mental and physical efforts, tunnel, numb limbs and tense tendons, amyotrophic treatment do not have specially good effect to half body.Can also prevent and treat diabetes, rheumatoid arthritis, lumbago and skelalgia effectively has certain curative effect, to preventing various tumors good effect is arranged also.
Using method: the ill initial stage can be taken 1-2 the course of treatment and can be cured.Cerebral infarction sequela is taken as conscious not dull-witted patient and can be cured 3 courses of treatment.10 days each courses of treatment, obey every day 2 times, each once obeys 2 grams at every turn sooner or later.
A kind of Chinese medicine preparation for the treatment of cardiovascular and cerebrovascular disease of the present invention is compared with prior art, have medication reasonable, evident in efficacy, have no side effect, prophylactic treatment all can, 1000 routine clinical proofs, effective percentage is 100%, cure rate 90% with first-class characteristics, thereby, have good value for applications.
Claims (1)
1. Chinese medicine preparation for the treatment of cardiovascular and cerebrovascular disease, the weight percent that it is characterized in that prescription consists of: Herba Taxilli 6-10%, Caulis Spatholobi 6-10%, Pheretima 3-7%, Radix Salviae Miltiorrhizae 8-12%, Flos Carthami 6-10%, Radix Astragali 6-10%, Herba Cynomorii 8-12%, Rhizoma Chuanxiong 8-12%, Radix Cyathulae 8-12%, Rhizoma Arisaematis 3-7%, Ramulus Uncariae Cum Uncis 2-6%, Bulbus Allii Macrostemonis 3-7%, Radix Rehmanniae 2-6%, Semen Strychni 3-7%, the said herbal medicine oven dry is ground into fine powder, is processed into various dosage form Chinese patent medicines then.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 97105867 CN1200278A (en) | 1997-05-26 | 1997-05-26 | Traditional Chinese medicine prepn. for treating cardiovascular and cerebrovascular disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 97105867 CN1200278A (en) | 1997-05-26 | 1997-05-26 | Traditional Chinese medicine prepn. for treating cardiovascular and cerebrovascular disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1200278A true CN1200278A (en) | 1998-12-02 |
Family
ID=5168161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 97105867 Pending CN1200278A (en) | 1997-05-26 | 1997-05-26 | Traditional Chinese medicine prepn. for treating cardiovascular and cerebrovascular disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1200278A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1088364C (en) * | 2000-05-29 | 2002-07-31 | 靳照礼 | Traditional Chinese medicine composition for treating ischemic encephalopathy and preparation process thereof |
| CN1090953C (en) * | 1999-03-19 | 2002-09-18 | 黄美益 | Preparation method and application of external medicine for treating cardiovascular and cerebrovascular diseases and rheumatism |
| CN1098701C (en) * | 1999-05-08 | 2003-01-15 | 吴景芳 | Synthetic orall liquid of red sage root |
| CN102309575A (en) * | 2010-06-29 | 2012-01-11 | 山东步长制药有限公司 | Application of medicinal composition in preparing medicament for treating diabetic complication |
| CN104013697A (en) * | 2014-05-16 | 2014-09-03 | 蒋理国 | Healthcare wine for regulating body channels and blood vessels |
| CN104940554A (en) * | 2015-07-27 | 2015-09-30 | 李万青 | Chinese herbal composition for treating heart diseases |
-
1997
- 1997-05-26 CN CN 97105867 patent/CN1200278A/en active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1090953C (en) * | 1999-03-19 | 2002-09-18 | 黄美益 | Preparation method and application of external medicine for treating cardiovascular and cerebrovascular diseases and rheumatism |
| CN1098701C (en) * | 1999-05-08 | 2003-01-15 | 吴景芳 | Synthetic orall liquid of red sage root |
| CN1088364C (en) * | 2000-05-29 | 2002-07-31 | 靳照礼 | Traditional Chinese medicine composition for treating ischemic encephalopathy and preparation process thereof |
| CN102309575A (en) * | 2010-06-29 | 2012-01-11 | 山东步长制药有限公司 | Application of medicinal composition in preparing medicament for treating diabetic complication |
| CN104013697A (en) * | 2014-05-16 | 2014-09-03 | 蒋理国 | Healthcare wine for regulating body channels and blood vessels |
| CN104940554A (en) * | 2015-07-27 | 2015-09-30 | 李万青 | Chinese herbal composition for treating heart diseases |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101066303B (en) | Medicine for treating cerebral thrombus, cerebral angiosclerosis, apoplexy and hemiplegia and its preparation | |
| CN102614387B (en) | The Chinese medicine composition of prevention and therapy apoplexy and preparation method | |
| CN1327882C (en) | Traditional Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease | |
| CN104027500A (en) | Traditional Chinese medicinal formula for treating high blood fat, hypercholesterolemia and high blood viscosity | |
| CN100998656A (en) | Medicated wine for tonifying bone and removing obstruction in channels | |
| CN1390585A (en) | Chinese medicine for detoxication purpose and its preparing process | |
| CN1200278A (en) | Traditional Chinese medicine prepn. for treating cardiovascular and cerebrovascular disease | |
| CN1994411A (en) | Medicine for treating cerebral apoplexy | |
| CN1814245A (en) | Chinese medicine remedy for treating cervical vertebra disease | |
| CN104758743A (en) | Traditional Chinese medicine foot fumigating powder for treating rheumatism as well as preparation method and using method thereof | |
| CN1686500A (en) | Chinese medicinal preparation for treating breast impediment | |
| CN101041006A (en) | Composite Chinese medicine took orally for treating coronary heart disease | |
| CN103735756A (en) | Traditional Chinese medicinal prescription for treating low back and leg pain | |
| CN1133458C (en) | Chinese herb medicine preparation for curing prolapse of lumbar intervertebral disk | |
| CN1107336A (en) | "Xiongbining" medicine for treatment of paralyticus thorax | |
| CN104338052A (en) | Formula of traditional Chinese medicine for treating cerebral thrombosis | |
| CN1382463A (en) | Chinese-medicinal capsule for treating cardiovascular and cerebrovascular diseases | |
| CN1090502C (en) | External use tradtional Chinese Medicine for treating hyperosteogeny, prolapse of lumbar intervertebral disc and various soft tissue injuries | |
| CN103083602B (en) | Externally used pharmaceutical composition for treating lumbar disease | |
| CN1162163C (en) | Chinese herbal medicinal liquor for curing rheumatic arthritis | |
| CN1052908C (en) | "Chanhouning" and its preparation method | |
| CN1308952A (en) | Chinese medicine for treating trigeminal neuraligia and its preparing process | |
| CN1628838A (en) | Composite formulation for treating bronchial asthma | |
| CN105641253A (en) | Medicinal liquor for preventing and treating cervical spondylosis and preparation method of medicinal liquor | |
| CN1872255A (en) | Oral liquid for apoplexia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |